Policybazaar Group injects Rs 362 Crore in docprime.com Medical Dialogues Bureau18 Sept 2018 1:49 PM ISTDocPrime is a new venture by the PolicyBazaar Group that owns India's leading insurance brand PolicyBazaar.com and top fintech marketplace...
Oxytocin sale to be regulated in Punjab Medical Dialogues Bureau18 Sept 2018 9:36 AM ISTPunjab: Aiming to put a check on misuse of Oxytocin, the State government has devised stringent measures to regulate Oxytocin sale in Punjab, informed...
Alembic Pharma gets USFDA nod for depressive disorder drug Medical Dialogues Bureau18 Sept 2018 9:32 AM ISTAlembic Pharma has recently received approval from USFDA to market its product which is a generic equivalent of Wyeth Pharma Inc's Pristiq...
Faulty hip implants: 15 patients seek relief from Health Ministry Medical Dialogues Bureau18 Sept 2018 9:00 AM ISTUnion Health Ministry said the panel has so far received representations from 15 affected patients from Faulty hip implants across the country and it...
Manipal Hospitals ropes in Rahul Dravid as brand ambassador Medical Dialogues Bureau17 Sept 2018 3:50 PM ISTManipal Hospitals, one of India’s leading healthcare provider today announced Mr Rahul Dravid, former Indian Cricketer as the brand ambassador. New...
Boehringer Ingelheim acquires ViraTherapeutics for 250 million dollars Medical Dialogues Bureau17 Sept 2018 3:50 PM IST ViraTherapeutics was a portfolio company of the two venture investors EMBL Ventures and the Boehringer Ingelheim Venture Fund (BIVF)has a transaction...
Glenmark Pharma receives USFDA approval for Estradiol Vaginal Insert Medical Dialogues Bureau17 Sept 2018 10:22 AM ISTGlenmark Pharma has received final approval from the US health regulator for the generic version of Nordisk Inc's VAGIFEM, used for providing relief...
Sanofi pledges to keep up its restructuring efforts Medical Dialogues Bureau17 Sept 2018 9:15 AM ISTPARIS: Sanofi will continue to implement cost savings after having reached a 1.5 billion euros ($1.75 billion) cost reduction target a year ahead of...
Takeda gets China approval for Whooping 62 Billion Dollar Shire purchase Medical Dialogues Bureau16 Sept 2018 9:52 AM ISTTakeda Pharmaceutical Co Ltd said that China approved its purchase of Shire Plc, the latest regulator to clear the $62 billion deal and bring the...
Regulators flag second impurity in Valsartan drug Medical Dialogues Bureau16 Sept 2018 9:08 AM ISTBlood pressure drug valsartan, produced by China’s Zhejiang Huahai Pharmaceutical, was this year found to contain traces of N-nitrosodimethylamine...
Roche steps up efficiency drive to take sting out of biosimilars Medical Dialogues Bureau16 Sept 2018 9:05 AM ISTLONDON/ZURICH: Roche, the world's biggest producer of cancer drugs, is stepping up cost cuts in an efficiency drive made unavoidable by competition...
Sun Pharma and SPARC's XELPROS gets USFDA approval Medical Dialogues Bureau15 Sept 2018 4:32 PM ISTUS Food and Drug Administration (USFDA) has approved the SPARC new drug application of XELPROS, used to reduce glaucoma open-angle glaucoma or ocular...
